Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with <sup>64</sup>Cu Using NOTA and NODAGA

<div>Comparison of <sup>64</sup>Cu-NOTA-ZHER2:S1, <sup>64</sup>Cu-NODAGA-ZHER2:S1, and <sup>68</sup>Ga-NODAGA-ZHER2:S1 biodistribution (a) and tumor-to-organ ratios (b) at 2 h after injection in mice bearing HER2-positive SKOV-3 xenografts. The data are presented as mean ± SD for four mice.</div>

Contrast Media & Molecular Imaging

fig5

Figure 5

Figure 5: Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with <sup>64</sup>Cu Using NOTA and NODAGA 

Contrast Media & Molecular Imaging

Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA

Figure 5

Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with ⁶⁴Cu Using NOTA and NODAGA